Back to results
US 2014/0212412 A1Published application
Use of il-33 antagonists to treat fibrotic disease
AssigneeMerck Sharp & Dohme Corp.
InventorsANDREW L. RANKIN, STEFAN PFLANZ, JOHN MUMM
Life of this patent
Estimating the term…
Abstract
Methods for treating fibrotic disease, such as idiopathic pulmonary fibrosis and scleroderma, with antagonists of IL-33 are disclosed.
Claims17
A method of treating a fibrotic disease in a subject comprising administering to said subject an antagonist of IL-33.
Dependencies are inferred from the claim text.